December 2017

As Trials Report Cardiovascular Outcomes Data, What About Microvascular Results?

December 18, 2017

Evidence-Based Diabetes Management

Evidence is more robust on kidney function but not sufficient to make drug decisions, one expert said. A whole separate trial, called CREDENCE, is examining renal function in patients taking canagliflozin.